Author: Shin Eun-Seok
Publisher: Springer Publishing Company
ISSN: 1569-5794
Source: The International Journal of Cardiovascular Imaging, Vol.28, Iss.7, 2012-10, pp. : 1643-1652
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
This study is aimed at assessing by intravascular ultrasound virtual histology (VH-IVUS) the effect of statins on coronary bifurcation atherosclerosis in non-culprit vessels. In this non-randomized study, in 48 patients, 51 bifurcation atherosclerotic sites in non-culprit vessels without significant angiographic stenosis, underwent baseline and 12 months follow-up VH-IVUS. Patients received treatment with either simvastatin (20 mg daily, n = 24) or rosuvastatin (10 mg daily, n = 24) for the same period. VH-IVUS analysis of bifurcation lesions included the 5-mm proximal, bifurcation only (side-branch point) and 5-mm distal subsegments. Overall plaque and external elastic membrane volume decreased after 1 year (115.7 ± 35.5 to 106.1 ± 29.3 mm³, P</i> < 0.001; and 241.0 ± 57.0 to 232.4 ± 54.2 mm³, P</i> = 0.005, respectively). Similarly, overall dense calcium volume significantly increased (7.1 ± 5.3 to 11.0 ± 8.5 mm³, P</i> < 0.010), while fibrous and fibrofatty volumes significantly decreased (36.9 ± 19.2 to 24.1 ± 11.7 mm³, P</i> < 0.001; and 5.1 ± 3.8 to 2.3 ± 2.0 mm³, P</i> < 0.001, respectively), and necrotic core volume did not change significantly (17.0 ± 11.1 to 19.8 ± 13.5 mm³, P</i> = 0.053). There were no significant differences in compositional analysis between the simvastatin and rosuvastatin treatment groups. However, within groups, necrotic core volume significantly increased in the simvastatin treatment group (19.7 ± 13.9 to 24.3 ± 16.1 mm³, P</i> = 0.029) but not in the rosuvastatin treatment group. (14.3 ± 6.7 to 15.6 ± 8.7 mm³, P</i> = 0.423). The independent clinical predictors for reduction of necrotic core volume by multiple stepwise logistic regression analysis were the percent change of HDL-cholesterol level (P</i> = 0.041, odds ratio: 1.052, 95% confidence interval (CI): 1.002 to 1.104) and the percent change of hsCRP level (P</i> = 0.021, odds ratio: 0.989, 95% CI: 0.980 to 0.998). After 1 year, overall dense calcium volume significantly increased whilst fibrous and fibrofatty volumes significantly decreased; no significant change in the content of necrotic core was observed. Although changes in the volumes of all plaque components were not significantly different between the simvastatin and rosuvastatin treatment groups, halting of necrotic core progression was apparent in the rosuvastatin group.
Related content
The International Journal of Cardiovascular Imaging, Vol. 29, Iss. 5, 2013-06 ,pp. :
By Jim Man-Hong Hau William Ko Ryan Siu Chung-Wah Ho Hee-Hwa Yiu Kai-Hang Lau Chu-Pak Chow Wing-Hing
Heart and Vessels, Vol. 25, Iss. 3, 2010-05 ,pp. :
By Candemir Basar Ertas Fatih Sinan Ozdol Cagdas Kaya Cansin Tulunay Kilickap Mustafa Akyurek Omer Atmaca Yusuf Kumbasar Deniz Erol Cetin
Clinical and Experimental Hypertension, Vol. 34, Iss. 6, 2012-10 ,pp. :